Victor Sandor - 13 Oct 2021 Form 4 Insider Report for Prelude Therapeutics Inc (PRLD)

Role
Director
Signature
/s/ Brian Piper, Attorney-in-Fact
Issuer symbol
PRLD
Transactions as of
13 Oct 2021
Net transactions value
$0
Form type
4
Filing time
14 Oct 2021, 18:56:26 UTC
Previous filing
22 Jun 2021
Next filing
05 Jan 2022
SEC
View on sec.gov

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction PRLD Director Stock Option (Right to Buy) Award $0 +8,022 $0.000000 8,022 13 Oct 2021 Common Stock 8,022 $15.81 Direct F1
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 The stock option vests as to 1/12 of the total shares monthly beginning on November 13, 2021 until fully vested, subject to the Reporting Person's provision of service to the Issuer on the vesting date.